Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis
Objectives The coronavirus disease 2019 (COVID-19) pandemic has prompted many initiatives to identify safe and efficacious treatments, yet little is known regarding where early efforts have focused. We aimed to characterise registered clinical trials assessing drugs or plasma treatments for COVID-19...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-06-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/6/e039978.full |